2025. Adverse reactions due to monoclonal antibodies in the treatment of allergic diseases. Group Positioning: Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA 2024-2025). Revista Alergia México. 72, 1 (Mar. 2025), 52–71. DOI:https://doi.org/10.29262/fsaxnm03.